Details for New Drug Application (NDA): 208259
✉ Email this page to a colleague
The generic ingredient in ROCKLATAN is latanoprost; netarsudil dimesylate. There are twenty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the latanoprost; netarsudil dimesylate profile page.
Summary for 208259
Tradename: | ROCKLATAN |
Applicant: | Alcon Labs Inc |
Ingredient: | latanoprost; netarsudil dimesylate |
Patents: | 17 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 208259
Generic Entry Date for 208259*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION/DROPS;OPHTHALMIC |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for NDA: 208259
Mechanism of Action | Rho Kinase Inhibitors |
Suppliers and Packaging for NDA: 208259
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ROCKLATAN | latanoprost; netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208259 | NDA | Alcon Laboratories, Inc. | 70727-529 | 70727-529-25 | 1 BOTTLE, PLASTIC in 1 CARTON (70727-529-25) / 2.5 mL in 1 BOTTLE, PLASTIC |
ROCKLATAN | latanoprost; netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208259 | NDA | Alcon Laboratories, Inc. | 70727-529 | 70727-529-99 | 1 BOTTLE, PLASTIC in 1 CARTON (70727-529-99) / 2.5 mL in 1 BOTTLE, PLASTIC |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.005%;EQ 0.02% BASE | ||||
Approval Date: | Mar 12, 2019 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jan 27, 2030 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Patented Use: | REDUCTION OF ELEVATED INTRAOCULAR PRESSURE | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jul 11, 2026 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | REDUCTION OF ELEVATED INTRAOCULAR PRESSURE | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 14, 2034 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Patented Use: | REDUCTION OF ELEVATED INTRAOCULAR PRESSURE |
Complete Access Available with Subscription